8 completed, 6 unknown. 4 Phase 1, 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
Follow Campylobacter Infections: new trials by email Literature Review of Campylobacter Infections trials Research Report on Campylobacter Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Recurrent Campylobacter Bacteraemia in Immunocompromised Patients Characteristics of patients and Campylobacter bacteraemia episodes - Campylobacter Infections | Unknown | Hospices Civils de Lyon | 30 | 2024-06-01 | 2024-05-29 | |
| Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study Management, progression and risk factors for failure of BJI caused by Campylobacter spp., Description of the evolution and risk factors for failure of osteoarticular infections caused by Campylobacter spp. - Campylobacter Infections | Unknown | Hospices Civils de Lyon | 200 | 2024-01-01 | 2024-05-22 | |
| Safety and Immunogenicity of CJCV2 With and Without ALFQ ALFQ, CJCV2 - Campylobacter Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 59 | 2022-09-13 | 2026-06-15 |
| LMN-101 in a Campylobacter Human Challenge Model LMN-101, Placebo - Campylobacter Infections | Phase 2 | Completed | Lumen Bioscience, Inc. | 42 | 2022-02-21 | 2025-09-25 |
| Protein Plus: Improving Infant Growth Through Diet and Enteric Health Azithromycin Oral Product, Placebos, Protein Supplement - Stunting, Malnutrition; Protein | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 5283 | 2018-09-23 | 2022-12-05 |
| Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders DNA Analysis of Blood Sample, Flexible sigmoidoscopy with colonic biopsies, Small bowel and colonic gastrointestinal permeability - Campylobacter Infections, Irritable Bowel Syndrome | Completed | Mayo Clinic | 120 | 2016-09-01 | 2022-01-20 | |
| Retrospective Study of Bone Infection Due to Campylobacter Spp Campylobacter Infections, Bone Diseases, Infectious | Completed | University Hospital, Brest | 10 | 2014-12-01 | 2016-08-31 | |
| Efficacy of Rifaximin in Preventing Campylobacteriosis Rifaximin intervention, Placebo intervention - Dysentery, Diarrhea | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 30 | 2014-10-01 | 2018-11-20 |
| Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders Stool culturing for pathogenic bacteria, Kato-Katz technique, Baermann technique - Soil-transmitted Helminthiasis, Schistosomiasis | Completed | Swiss Tropical & Public Health Institute | 2800 | 2014-07-01 | 2016-10-25 | |
| Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea Capsule-Conjugate Campylobacter Vaccine (CJCV1), Alhydrogel®, aluminum hydroxide adjuvant (alum) - Campylobacter Infection | Phase 1 | Completed | U.S. Army Medical Research and Development Command | 48 | 2014-04-21 | 2018-02-23 |
| Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota Campylobacter Infections, Irritable Bowel Syndrome | Unknown | University of Nottingham | 450 | 2013-01-01 | 2017-05-04 | |
| Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection Campylobacter jejuni strain CG8421 - Campylobacter Infections | Phase 1 | Unknown | University of Vermont | 16 | 2010-01-01 | 2010-01-13 |
| ACE393-103 Vaccination Challenge Study ACE393, Placebo vaccine - Campylobacter Infection | Phase 2 | Unknown | TD Vaccines A/S | 72 | 2008-10-01 | 2009-03-11 |
| Campylobacter Jejuni Challenge Model Development: Dose Ranging Study Campylobacter jejuni strains CG8421 and BH-01-0142 - Campylobacter Infections | Phase 1 | Unknown | University of Vermont | 50 | 2007-02-01 | 2008-06-05 |
Diarrhea (4) · Irritable Bowel Syndrome (2) · Abdominal Pain (1) · Amebiasis (1) · Bone Diseases, Infectious (1) · Dientamoebiasis (1) · Dysentery (1) · Dysentery, Bacillary (1) · Enteritis (1) · Gastroenteritis (1) · Giardiasis (1) · Growth Disorders (1) · Kwashiorkor (1) · Primary Immunodeficiency Diseases (1)
Bacterial Infections (14) · Bacterial Infections and Mycoses (14) · Gram-Negative Bacterial Infections (14) · Infections (14) · Digestive System Diseases (5) · Gastrointestinal Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Intestinal Diseases (4) · Signs and Symptoms (4) · Signs and Symptoms, Digestive (4) · Gastroenteritis (3) · Colonic Diseases (2) · Colonic Diseases, Functional (2) · Bone Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Aluminum Hydroxide (1) · Eggs (1) · Multiplex Polymerase Chain Reaction (1) · Nutrition Assessment (1) · Risk Factors (1) · Starch (1) · Therapeutics (1) · aluminum sulfate (1)
Hospices Civils de Lyon (2) · Johns Hopkins Bloomberg School of Public Health (2) · University of Vermont (2) · Lumen Bioscience, Inc. (1) · Mayo Clinic (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Swiss Tropical & Public Health Institute (1) · TD Vaccines A/S (1) · U.S. Army Medical Research and Development Command (1) · University Hospital, Brest (1) · University of Nottingham (1)
United States (8) · France (3) · Bangladesh (1) · Côte d’Ivoire (1) · Indonesia (1) · Mali (1) · Nepal (1) · United Kingdom (1)
Amanda C Palmer, PhD (1) · Beth Kirkpatrick, MD (1) · David Tribble, MD (1) · Giles AD Major, BM BCh MRCP (1) · Katja Polman, PhD (1) · Kawsar Talaat, M.D. (1) · Madhusudan Grover, MBBS (1) · Marleen Boelaert, PhD (1) · Mathew Diggle, MSc PhD (1) · Md Iqbal Hossain, PhD (1) · Miranda Lomer, PhD RD (1) · Mohamed Al-Ibrahim, MB,ChB, FACP (1) · Mohamed Al-Ibrahim, MD (1) · Ramiro Gutierrez, MD (1)
PMID 23840001, PMID 11692292, PMID 12809830, PMID 15017618, PMID 17382603, PMID 18809665, PMID 19842970, PMID 20086085, PMID 20412178, PMID 21050319, PMID 21896097, PMID 22864805, PMID 26282537, PMID 29145631, PMID 30074085, PMID 36171082, PMID 38413997, PMID 38759886, PMID 39788294
5UM1AI148372-03 (1), K23DK103911 (1), P30DK084567 (1), UL1TR000135 (1)